A study titled "Association Between Electronic Cigarette Use and Visual Impairment in the United States" analyzed data from 1,173,646 adults aged 18 to 50 years old between 2016 and 2018. The results showed that electronic cigarette users were 34% more likely to develop visual impairment compared to non-users, and that their likelihood of developing visual impairment was 14% higher.
The team has demonstrated that solvents in e-cigarette liquids damage tear ducts and cause "oxidative stress" in the body, which is related to impaired vision.
A recent study published in the journal "Nicotine and Tobacco Research" by University of California, Los Angeles emphasized the relative safety of smokeless tobacco products and how transitioning from combustible cigarettes to these products could reduce the risk of cardiovascular disease among smokers.
The link between smokeless tobacco products and heart health
The study was conducted by a team of researchers from the University of California, Los Angeles, the University of California, San Francisco, Boston University, and the University of Texas at Arlington.
As part of the Population Assessment of Tobacco and Health (PATH) study, researchers analyzed data from a nationally representative sample of 4,347 adults who provided urine and blood samples during 2013-14. Of these participants, 3,034 reported using cigarettes only, 338 reported using smokeless tobacco only, and 975 reported never using any tobacco products.
According to compiled data, biomarkers for disease in non-smokers of tobacco products are significantly lower despite similar nicotine levels. "Our findings suggest that, despite higher nicotine content, the concentration of inflammatory and oxidative stress biomarkers is significantly lower in non-smokers of tobacco products compared to smokers," said Mary Rezk-Hanna, assistant professor at the UCLA School of Nursing. She added that the levels of these biomarkers in non-smokers of tobacco products are similar to those of individuals who have never smoked.
Statement:
This article is compiled from third-party information and is intended for industry exchange and learning purposes only.
This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness or accuracy of the content. The translation of this article is only intended for industry communication and research purposes.
Due to limitations in translation proficiency, the translated article may not fully express the same message as the original text. Please refer to the original text for accuracy.
2FIRSTS is completely aligned with the Chinese government on all domestic, Hong Kong, Macau, Taiwan, and foreign issues and positions.
The compilation of information is the property of the original media and authors. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
